Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals, a subsidiary of Mylan, has introduced Oxycodone and Aspirin tablets USP, 4.8355mg/325mg.
Subscribe to our email newsletter
Mylan Pharma has launched the drug under its collaboration pact with Coastal Pharmaceuticals.
The drug is the generic version of Endo Pharmaceuticals‘ Percodan tablets, used as a treatment for moderate to severe pain.
Percodan tablets contain a mixture of 325mg of aspirin and 4.8355mg of oxycodone HCl (equivalent to 4.3346 mg of oxycodone as the free base).